How Much Does Wegovy Cost?

At the US pharmacies in our data, the lowest listed discount-card price for Wegovy is around $1,010.50. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.

Canadian pharmacy listings in our data show Wegovy priced from about $5.83 per tablet (converted to USD), before shipping. Pack size and pharmacy both affect the final total — see the Canada pricing table for specifics.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Wegovy.

Generic and brand-name pricing for Wegovy is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

Insurance coverage can substantially lower the cost of Wegovy, but the exact copay or coinsurance amount depends entirely on your specific plan's formulary and benefit design. It's essential to contact your insurer for details on coverage criteria and patient responsibility. If your plan does not cover Wegovy or leaves you with a high copay, comparing the price using a pharmacy discount program against your insurance copay can help ensure you pay the lowest available price for each refill.

Coverage for Wegovy varies widely among commercial insurance plans. Some plans cover it for weight management, while others may only authorize it for cardiovascular risk reduction in patients with specific conditions. Because each plan's policies are unique, you must verify coverage directly with your insurance provider.

Traditional Medicare Part D plans generally do not cover medications prescribed solely for weight loss. However, coverage may be available for Wegovy when used to reduce cardiovascular risk in eligible patients. It is important to note that Medicare coverage policies for GLP-1 medications are anticipated to evolve in the coming years.